Gefitinib potentiates myeloid cell differentiation by ATRA.
作者信息
Miranda M B, Duan R, Thomas S M, Grandis J R, Redner R L, Jones J E, Johnson D E
出版信息
Leukemia. 2008 Aug;22(8):1624-7. doi: 10.1038/leu.2008.28. Epub 2008 Feb 28.
Abstract
摘要
相似文献
1
Gefitinib potentiates myeloid cell differentiation by ATRA.
Leukemia. 2008 Aug;22(8):1624-7. doi: 10.1038/leu.2008.28. Epub 2008 Feb 28.
2
EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells.
Cell Cycle. 2013 Sep 15;12(18):2978-91. doi: 10.4161/cc.26016. Epub 2013 Aug 13.
3
Dasatinib promotes ATRA-induced differentiation of AML cells.
Leukemia. 2010 Mar;24(3):663-5. doi: 10.1038/leu.2009.267. Epub 2009 Dec 24.
4
Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells.
Int J Hematol. 2010 Jul;92(1):136-43. doi: 10.1007/s12185-010-0627-4. Epub 2010 Jun 18.
5
All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
PLoS One. 2015 Jun 5;10(6):e0127790. doi: 10.1371/journal.pone.0127790. eCollection 2015.
6
Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
J Biol Chem. 2015 Apr 24;290(17):10599-609. doi: 10.1074/jbc.M114.634790. Epub 2015 Mar 3.
7
Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
Int J Cancer. 2009 Oct 1;125(7):1710-20. doi: 10.1002/ijc.24472.
8
KLFs and ATRA-induced differentiation: new pathways for exploitation.
Leuk Res. 2011 Jul;35(7):846-7. doi: 10.1016/j.leukres.2011.04.002. Epub 2011 May 4.
9
Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Mol Carcinog. 2011 Jan;50(1):24-35. doi: 10.1002/mc.20687.
10
Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
Mol Cancer Ther. 2013 Feb;12(2):195-206. doi: 10.1158/1535-7163.MCT-12-0433. Epub 2012 Dec 13.
引用本文的文献
1
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.
Front Oncol. 2021 Sep 28;11:686445. doi: 10.3389/fonc.2021.686445. eCollection 2021.
2
Pardaxin Promoted Differentiation and Maturation of Leukemic Cells via Regulating TLR2/MyD88 Signal against Cell Proliferation.
Evid Based Complement Alternat Med. 2019 Feb 24;2019:7035087. doi: 10.1155/2019/7035087. eCollection 2019.
3
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia.
Onco Targets Ther. 2016 Jul 20;9:4453-64. doi: 10.2147/OTT.S105664. eCollection 2016.
4
Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity.
PLoS One. 2014 Jun 11;9(2):e98859. doi: 10.1371/journal.pone.0098859. eCollection 2014.
5
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia.
Leuk Res. 2014 Apr;38(4):430-4. doi: 10.1016/j.leukres.2013.10.026. Epub 2013 Nov 5.
6
MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia.
PLoS One. 2013 Jun 25;8(6):e66915. doi: 10.1371/journal.pone.0066915. Print 2013.
7
Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells.
PLoS One. 2011;6(12):e29014. doi: 10.1371/journal.pone.0029014. Epub 2011 Dec 22.
8
Ganoderma lucidum Polysaccharides Induce Macrophage-Like Differentiation in Human Leukemia THP-1 Cells via Caspase and p53 Activation.
Evid Based Complement Alternat Med. 2011;2011:358717. doi: 10.1093/ecam/nep107. Epub 2011 Jan 4.
本文引用的文献
1
Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiation.
Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3081-90. doi: 10.1158/1535-7163.MCT-07-0514. Epub 2007 Dec 7.
2
Signal transduction pathways that contribute to myeloid differentiation.
Leukemia. 2007 Jul;21(7):1363-77. doi: 10.1038/sj.leu.2404690. Epub 2007 Apr 19.
3
The design of selective and non-selective combination therapy for acute promyelocytic leukemia.
Curr Top Microbiol Immunol. 2007;313:245-69. doi: 10.1007/978-3-540-34594-7_13.
4
Gefitinib induces myeloid differentiation of acute myeloid leukemia.
Blood. 2005 Oct 15;106(8):2841-8. doi: 10.1182/blood-2005-02-0488. Epub 2005 Jul 5.
5
A small molecule-kinase interaction map for clinical kinase inhibitors.
Nat Biotechnol. 2005 Mar;23(3):329-36. doi: 10.1038/nbt1068. Epub 2005 Feb 13.
6
Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Leukemia. 2002 Apr;16(4):683-92. doi: 10.1038/sj.leu.2402400.
7
Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer.
Bioorg Med Chem Lett. 2001 Jul 23;11(14):1911-4. doi: 10.1016/s0960-894x(01)00344-4.
8
A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients.
Blood. 1991 Sep 15;78(6):1413-9.
Zotero 插件